Mexico and Argentina have reached agreement with AstraZeneca to produce for Latin America the Covid-19 vaccine that it is developing with Oxford University
Clinical trials are expected to be completed in November or December, and production could begin in early 2021
President Vladimir Putin said that Russia has officially registered the world’s first coronavirus vaccine. WSJ’s Thomas Grove explains how Moscow reached this milestone faster than anyone else, and what we know about the drug. Photo: Alexander Zemlianichenko Jr/Associated PressMEXICO CITY—Mexico and Argentina have reached agreement with U.K. pharmaceutical company AstraZeneca PLC to produce for Latin America the Covid-19 vaccine that it is developing with Oxford University.
Clinical trials under way are expected to be completed in November or December, and production could begin in early 2021 if they are successful.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Mexico Has a Second Pandemic: FemicideFemicide cases in Mexico have increased by 137 percent in the last five years.
Read more »
Mexico reports 6,686 new coronavirus cases, 926 more deathsMexico's health ministry on Tuesday reported 6,686 new confirmed coronavirus cases and 926 additional fatalities, bringing the totals in the country to 492,522 infections and 53,929 deaths.
Read more »
Mexico Has a Second Pandemic: FemicideFemicide cases in Mexico have increased by 137 percent in the last five years.
Read more »
Mexico to conduct trials for China, U.S. COVID-19 vaccines, eyes productionMexico aims to conduct late-stage clinical trials for COVID-19 vaccines in development by U.S. and Chinese companies, two of which might base some of their vaccine production in the country, the foreign ministry said on Tuesday.
Read more »
Mexico City Reopens Bars And Cinemas To Try And Save Economy, Despite Coronavirus OutbreakBars that serve food, museums, theaters and pools in Mexico City will be permitted to open up to 30% capacity.
Read more »
'Reckless and foolish': Why Russia's vaccine has experts alarmedThe FDA has said that any potential coronavirus vaccine will need to be at least 50% effective to be approved, which means the vaccine would need to prevent infections in at least 50% of the people who receive it.
Read more »